Sedatives like Ambien and Lunesta alleviate bedtime woes of many Americans who suffer from insomnia and other sleep disorders, however, like any prescription medication, the desired effects come at a cost. Many who have used the medication report a hangover of sorts—grogginess that carries into the next day, impaired attention and memory are just a few of the reported side effects.
Amidst FDA recommendations for doctors to limit Ambien prescriptions, especially to women, an experimental drug has emerged as a sedative used to promote sleep but without the undesired side effects of grogginess and impaired motor skills. The medication, called DORA-22, is still in experimental stages but promises to induce sleep without impairing cognitive functioning of the recipient.
Comments are closed.